TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
Chi M, Liu J, Mei C, Shi Y, Liu N, Jiang X, Liu C, Xue N, Hong H, Xie J, Sun X, Yin B, Meng X, Wang B.
Chi M, et al.
J Exp Clin Cancer Res. 2022 May 17;41(1):175. doi: 10.1186/s13046-022-02377-3.
J Exp Clin Cancer Res. 2022.
PMID: 35581606
Free PMC article.